Progressive adoption of cryoablative therapy for breast fibroadenoma in community practice.
|
| Abstract | BACKGROUND:
Cryoablation is a recent technological advance and has been used for the percutaneous treatment of breast fibroadenomas. Herein, we provide a retrospective summary of the early experience from a nationwide group. METHODS: We organized a national registry to document the community practice and adoption of an office-based system of cryoablation for breast fibroadenoma. Data were abstracted during the first 6 weeks after the procedure to assess acute outcome and potential complications. At 6-and 12-month follow-up intervals, additional data were collected regarding fibroadenoma resolution, cosmesis, and patient satisfaction. RESULTS: Fifty-three sites ablated 310 fibroadenomas. Early follow-up data on 256 lesions showed that the procedure was well tolerated with infrequent minor complications immediately after the procedure. At 6 and 12 months postprocedure, the remaining fibroadenoma volume progressively involuted. At both intervals, cosmesis was excellent, and patient satisfaction was rated high. CONCLUSIONS: An early community experience with office-based cryoablation of breast fibroadenomas is encouraging and comparable to the initial experience of high-volume tertiary centers. More follow-up is necessary to determine long-term results and residual mammographic changes.
|
|---|---|
| Authors | Michael J Edwards, Ralph Broadwater, Lorraine Tafra, Daleela Jarowenki, Charles Mabry, Peter Beitsch, Pat Whitworth, Robert C Martin, Lori Oetting |
| Journal | American journal of surgery (Am J Surg) Vol. 188 Issue 3 Pg. 221-4 (Sep 2004) ISSN: 0002-9610 [Print] United States |
| PMID | 15450823 (Publication Type: Journal Article, Multicenter Study) |
| Copyright | Copyright 2004 Excerpta Medica, Inc. |
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!